Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with Caspofungin - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Journal of Clinical Microbiology Année : 2011

Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with Caspofungin

Résumé

Hormographiella aspergillata, a filamentous basidiomycete, has rarely been involved in human infections. We describe 2 febrile neutropenic patients who developed a severe pulmonary infection due to H. aspergillata while receiving empirical caspofungin therapy for presumed fungal pneumonia. After introduction of liposomal amphotericin B, one patient, who had neutrophil recovery, presented a favorable outcome, while the other, who remained neutropenic throughout the course of infection, died. Resistant fungi, including basidiomycetes, may emerge during empirical treatment with caspofungin in febrile neutropenic patients. A rapid switch to any other potent antifungal should be rapidly considered in case of failure of caspofungin in this setting.

Domaines

Mycologie

Dates et versions

pasteur-02262452 , version 1 (02-08-2019)

Identifiants

Citer

Felipe Suarez, Olivier Olivier, Dea Garcia-Hermoso, Edouard Randriamalala, David Ghez, et al.. Breakthrough Hormographiella aspergillata Infections Arising in Neutropenic Patients Treated Empirically with Caspofungin. Journal of Clinical Microbiology, In press, 49 (1), pp.461-465. ⟨10.1128/JCM.01213-10⟩. ⟨pasteur-02262452⟩
32 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More